Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-21-027408

CEO acquired 125,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Woods Lori A · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-23 Exercise or conversion : show line 1 in the form +62,500 $0.46 $28,750 909,538 I
2021-11-23 Exercise or conversion : show line 2 in the form +62,500 $0.43 $26,875 972,038 I

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-11-23 Exercise or conversion : show line 3 in the form Stock Options (right to buy) −62,500 0 D
2021-11-23 Exercise or conversion : show line 4 in the form Stock Options (right to buy) −62,500 62,500 D
Loading xslF345X03/rdgdoc.xml…